Fluorometric Determination of Cyanate in Plasma by Conversion to 2,4(1 H,3 H)-Quinazolinedione and Separation by High-Performance Liquid Chromatography

A fluorometric high-performance liquid-chromatographic method is described for the determination of cyanate in human plasma. The method is based on the determination of cyanate with 2-aminobenzoic acid (anthranilic acid), leading to a stable cyclic fluorescent product, 2,4(1 H,3 H)-quinazolinedione....

Full description

Saved in:
Bibliographic Details
Published inAnalytical biochemistry Vol. 211; no. 1; pp. 23 - 27
Main Authors Lundquist, P., Backmangullers, B., Kagedal, B., Nilsson, L., Rosling, H.
Format Journal Article
LanguageEnglish
Published San Diego, CA Elsevier Inc 15.05.1993
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A fluorometric high-performance liquid-chromatographic method is described for the determination of cyanate in human plasma. The method is based on the determination of cyanate with 2-aminobenzoic acid (anthranilic acid), leading to a stable cyclic fluorescent product, 2,4(1 H,3 H)-quinazolinedione. The fluorescent product was extracted with ethyl acetate, passed through a cation-exchange resin to eliminate the excess of determination reagent, and then concentrated on a Sep-Pak C-18 cartridge before reversed-phase chromatography and fluorometric detection. The precision of the method was satisfactory (coefficient of variation 2.3%) and the analytical recovery was quantitative (103%). Detection limit was found to be 8 nmol/liter from a 1-ml plasma sample. Cyanate in plasma was stable for 3 months when stored in liquid nitrogen. The mean and SD cyanate level in human plasma from 17 healthy nonsmoking subjects was 45 ± 21 nmol/liter.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0003-2697
1096-0309
DOI:10.1006/abio.1993.1226